pharmaceutical formulation comprising one or more éstreres of fumaric acid in a matrix erosion

@inproceedings{Nilsson2010pharmaceuticalFC,
  title={pharmaceutical formulation comprising one or more {\'e}streres of fumaric acid in a matrix erosion},
  author={Henrik Nilsson and Roland Rupp},
  year={2010}
}
pharmaceutical formulation of a tablet erosion matrix comprising: i) from 10% to 80% by weight of one or more fumaric acid esters selected from alkyl diesters (C1-C5) of fumaric acid monoesters and alkyl (C1- C5) of fumaric acid, or a pharmaceutically acceptable salt thereof, as active ingredient; ii) 1-50% by weight of one or more agents speed control; and an enteric coating, wherein said enteric coating is applied at a level of 1.5-3.5% by weight of the core, wherein the erosion of said… CONTINUE READING